Nordic Capital wins award for “Nordic Deal of the Year” following its sale of AniCura
April 26 2019
- The sale represented one of the largest ever transactions in the vet care sector
Nordic Capital scooped the award for “Nordic Deal of the Year” at this year’s Real Deals Private Equity Awards for the successful sale of leading European vet care provider AniCura, which it sold in 2018 to Mars Petcare.
The awards, held at the London Hilton on Park Lane on April 24, recognise the very best performers in European private equity. The shortlist was assembled following research carried out by Real Deals and Cass Business School and findings were presented to a judging panel for final deliberation.
The judges described the AniCura deal as “incredible” and praised the firm for the huge amount of work done to create significant value.
During Nordic Capital’s four-year ownership period, Nordic Capital helped AniCura to grow fourfold, shaping the European vet care landscape by creating a specialised clinic business with high quality pet care at its core. It increased the number of its clinics from 50 to over 200, its employees numbers from 1,000 to 4,000 and its pro forma revenues from approx. SEK 0.9 bn to SEK 3.3 bn.
Thomas Vetander, Partner, Advisor to the Nordic Capital Funds said: “We are very proud to have won this award which reflects the hard work and dedication of the AniCura team. AniCura is an excellent example of an entrepreneurial and innovative business that puts compassion for patients and pet owners at its heart. Its strong and differentiated corporate culture is focused on ensuring the highest quality care as well as nurturing a strong sense of teamwork across its broad base of international clinics and this makes it unique in Europe”.
Vetander continued: “We are seeing a wealth of opportunities within the healthcare sector where Nordic Capital has significant investment experience of supporting management teams and founders in their journey to becoming global leaders”.
Nordic Capital has a long history and proven track record of investing into the healthcare sector. This includes making 28 investments with a total equity investment of EUR 5.5 bn in leading companies such as Nycomed, Permobil and Capio. In the last 18 months, five new platform investments have been made in the healthcare sector by Nordic Capital (including by its latest EUR 4.3 bn fund, Nordic Capital Fund IX), such as Ober Scharrer Group (outpatient ophthalmologic treatments), European Dental Group (dental services) and Alloheim (care service provider).
Katarina Janerud, Communications Manager
Advisor to the Nordic Capital Funds
Tel: +46 8 440 50 50
About Nordic Capital
Nordic Capital is a leading private equity investor with a resolute commitment to creating stronger, sustainable businesses through operational improvement and transformative growth. Nordic Capital focuses on selected regions and sectors where it has deep experience and a proven track record. Core sectors are Healthcare, Technology & Payments, Financial Services and in addition Industrial Goods & Services and Consumer. Key regions are the Nordics, Northern Europe and globally for Healthcare. Since inception in 1989, Nordic Capital has invested EUR 14 billion in over 100 investments. The most recent fund is Nordic Capital Fund IX with EUR 4.3 billion in committed capital, principally provided by international institutional investors such as pension funds. The Nordic Capital Funds and vehicles are based in Jersey and are advised by advisory entities, which are based in Sweden, Denmark, Finland, Norway, Germany and the UK. For further information about Nordic Capital, please visit www.nordiccapital.com